Aligos Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALGS Nasdaq 2836 www.aligos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aligos Therapeutics, Inc.

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC) - Jun 18th, 2025 6:00 am
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 13th, 2025 6:00 am
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference - May 29th, 2025 6:00 am
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - May 20th, 2025 6:00 am
Aligos Therapeutics First Quarter 2025 Earnings: Revenues Miss Expectations - May 11th, 2025 6:36 am
Aligos Therapeutics Presents Positive Data at the EASL Congress 2025 - May 8th, 2025 6:00 am
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates - May 6th, 2025 7:35 am
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - May 6th, 2025 6:00 am
UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls - May 1st, 2025 7:40 am
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025 - Apr 29th, 2025 6:30 am
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025 - Apr 23rd, 2025 2:05 pm
Aligos Therapeutics Presents Positive Data at APASL 2025 - Mar 26th, 2025 6:00 am
Biotech Alert: Searches spiking for these stocks today - Mar 14th, 2025 10:15 am
Aligos Therapeutics, Inc. (ALGS) Reports Q4 Loss, Lags Revenue Estimates - Mar 10th, 2025 7:25 am
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - Mar 10th, 2025 6:00 am
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - Mar 3rd, 2025 6:00 am
Aligos Therapeutics Announces $105 Million Private Placement Financing - Feb 12th, 2025 5:00 am
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Feb 8th, 2025 5:33 am
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Feb 4th, 2025 3:01 am
Here’s Why Aligos Therapeutics, Inc. (ALGS) Is Skyrocketing - Jan 13th, 2025 2:32 pm